Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02520791
What this trial is testing

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Who this might be right for
Advanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT05788289
What this trial is testing

Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell LymphomaMCL
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05607420
What this trial is testing

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Cellectis S.A. 80
Early research (Phase 1)Study completedNCT00060684
What this trial is testing

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more
CTI BioPharma 30
Early research (Phase 1)Looking for participantsNCT07532525
What this trial is testing

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more
University of Michigan Rogel Cancer Center 12
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Active Not RecruitingNCT05395533
What this trial is testing

TRS005 in Patients With R/R CD20-positive B-NHL.

Who this might be right for
CD20-positive B-cell Non-Hodgkin Lymphoma
Zhejiang Teruisi Pharmaceutical Inc. 147
Large-scale testing (Phase 3)Not Yet RecruitingNCT05700448
What this trial is testing

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
CStone Pharmaceuticals 150
Testing effectiveness (Phase 2)Study completedNCT02953652
What this trial is testing

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma (PTCL)
HUYABIO International, LLC. 55
Early research (Phase 1)Study completedNCT01129193
What this trial is testing

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more
Amir Mortazavi 44
Testing effectiveness (Phase 2)Ended earlyNCT00089284
What this trial is testing

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
Northwestern University 30
Early research (Phase 1)Looking for participantsNCT07838714
What this trial is testing

Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Ruijin Hospital 18
Early research (Phase 1)Active Not RecruitingNCT04447716
What this trial is testing

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more
Thomas Jefferson University 4
Very early researchNot Yet RecruitingNCT07584850
What this trial is testing

Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Ruijin Hospital 9
Early research (Phase 1)Study completedNCT00457782
What this trial is testing

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)WithdrawnNCT03873025
What this trial is testing

CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
University College, London
Early research (Phase 1)Looking for participantsNCT06559189
What this trial is testing

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
University of Colorado, Denver 53
Not applicableStudy completedNCT05338879
What this trial is testing

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Follicular Lymphoma
Regeneron Pharmaceuticals 247
Testing effectiveness (Phase 2)Study completedNCT03534180
What this trial is testing

Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center 12
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Next Page